About our Department
Our research
At the department of Hematology we are dedicated to improving the diagnosis and treatment of patients with hematological diseases. We perform basic and translational research to generate insight into the pathobiology of hematological diseases, and translate these findings into novel treatments for our patients.
In addition, we direct a wide variety of clinical studies, closely linked to our preclinical programs. These clinical studies deal with the development of molecular diagnostics, advancement of allogeneic stem cell transplantation, circumvention of drug-resistance to chemotherapy as well as a broad range of clinical phase I to phase III trials for a variety of hematological diseases.
For more information on specific research lines please select a principle investigator from the list below or select a particular hematological disease in the list of research lines.
For more information on clinical care for patients with hematological diseases please see our clinical homepage.
Follow this link to see all our studies.
Principal Investigators
- Ruben Bierings
- Jan Cornelissen
- Tom Cupedo
- Mojca Jongen-Lavrencic
- Ruud Delwel
- Frank Leebeek
- Bob Löwenberg
- Moniek de Maat
- Emma de Pater
- Marc Raaijmakers
- Dick Rijken
- Pieter Sonneveld
- Ivo Touw
- Peter Valk
Research lines
Acute Myeloid Leukemia (AML)
- Ruud Delwel
- Mojca Jongen-Lavrencic
- Bob Löwenberg
- Peter Valk
Severe Congenital Neutropenia
- Ivo Touw
Hematopoiesis and Stem Cell Transplantation
- Jan Cornelissen
- Emma de Pater
Hemostasis & Thrombosis
- Ruben Bierings
- Frank Leebeek
- Monique de Maat
- Dick Rijken
Myelodisplastic Syndrome
- Marc Raaijmakers
- Rebecca Schneider-Kraman
Multiple Myeloma
- Tom Cupedo
- Pieter Sonneveld
